U.S. markets open in 12 minutes

Regulus: 1Q Earnings Snapshot

SAN DIEGO (AP) _ Regulus Therapeutics Inc. (RGLS) on Thursday reported a loss of $5.9 million in its first quarter.

On a per-share basis, the San Diego-based company said it had a loss of 25 cents.

The biopharmaceutical company posted revenue of $6 million in the period.

In the final minutes of trading on Thursday, the company's shares hit 66 cents. A year ago, they were trading at $1.45.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGLS at https://www.zacks.com/ap/RGLS